Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm March 17, 2024 Categories: Health Care Tags: Relation Therapeutics
Relation Therapeutics opens flagship lab in London March 6, 2023 Categories: Health Care Tags: Relation Therapeutics
Relation Therapeutics, the active-graph machine learning drug discovery company, names David Roblin as CEO and Lindsay Edwards as CTO June 10, 2022 Categories: Health Care Tags: Relation Therapeutics
